Rapid progression and brain atrophy in anti-AMPA receptor encephalitis-Reference-Cited by-同舟云学术

Rapid progression and brain atrophy in anti-AMPA receptor encephalitis

Published:2013-08 Issue:1-2 Volume:261 Page:129-133
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Wei Yi-Chia,Liu Chi-Hung,Lin Jainn-Jim,Lin Kun-Ju,Huang Ko-Lun,Lee Tsong-Hai,Chang Yeu-Jhy,Peng Tsung-I,Lin Kuang-Lin,Chang Ting-Yu,Chang Chien-Hung,Kuo Hung-Chou,Chang Kuo-Hsuan,Cheng Mei-Yun,Huang Chin-Chang

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference23 articles.

1. 17Beta-estradiol increases astrocytic vascular endothelial growth factor (VEGF) in adult female rat hippocampus;Barouk;Endocrinology,2011

2. The GLUR2 subunit of AMPA receptors: synaptic role;Bassani;Neuroscience,2009

3. Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor;Bataller;Neurology,2010

4. AMPA receptors as drug targets in neurological disease—advantages, caveats, and future outlook;Chang;Eur. J. Neurosci.,2012

5. The adaptation of the cerebral circulation to pregnancy: mechanisms and consequences;Cipolla;J. Cereb. Blood Flow Metab.,2013

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune encephalitis during pregnancy: A diagnostic and therapeutic challenge—A systematic review with individual patients' analysis and clinical recommendations;Epilepsia Open;2023-09-15

2. Anti-metabotropic-glutamate-receptor 2-related encephalitis with cerebellar ataxia: a case description;Quantitative Imaging in Medicine and Surgery;2023-07

3. Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis;Neurological Sciences;2023-04-03

4. Neural Surface Antibodies and Neurodegeneration: Clinical Commonalities and Pathophysiological Relationships;Biomedicines;2023-02-22

5. Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know?;Frontiers in Neurology;2022-12-19